Trials / Completed
CompletedNCT00803712
20070360 Incident Dialysis
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination With Low Dose Vitamin D for the Treatment of Subjects With Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 313 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cinacalcet | Cinacalcet is a calcimimetic agent, which is synthesized as a hydrochloride salt. |
| DRUG | Vitamin D | Titration of active Vitamin D in accordance with treatment practice guidelines in order to treat Secondary Hyperparathyroidism. |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-12-09
- Completion
- 2011-07-05
- First posted
- 2008-12-05
- Last updated
- 2018-10-17
- Results posted
- 2014-03-12
Source: ClinicalTrials.gov record NCT00803712. Inclusion in this directory is not an endorsement.